Colleagues of University of Michigan neurologist Sidney Gilman were
shocked when the U.S. government revealed a massive insider
trading scheme that was based on his
conversations with a hedge fund analyst. The two men were brought
together by a so-called
expert network firm, and according to documents
in the U.S. district court in New York, the analyst generated ill-gotten
gains
through stock trades based on confidential
information he gained from Gilman about the results of a clinical trial
for a new
Alzheimer's drug. The case is the latest in a
string of high-profile prosecutions that have focused attention on this
little-known
world of so-called expert network firms. To find
out how such expert network firms operate, and why a researcher would
participate,
Science interviewed one firm's top-rated experts in health care.
إرسال تعليق